Jeffrey Farrow - Chief Financial Officer and Chief Strategy Officer at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer and Chief Strategy Officer
Stock Symbol
TARS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Jeffrey Farrow - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Jeffrey Farrow for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 22.4K $1.12M $50.11 Mar 20, 2025 Direct
Stock Option (right to buy) 30.6K $337K $10.99 Mar 5, 2025 Direct Common Stock
Restricted Stock Units 24.1K $310K $12.89 Mar 17, 2025 Direct Common Stock

Transactions reported by Jeffrey Farrow for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.